About: Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China
Creator	Wang, & Gonzalez, R Yin, Y Zhao, F Bai, L Cao, B Guo, P Liu, Y.-M Ren, L.-L Song, S.-F Wang, J.-W Zhang, J.-Z Zhang, Y.-Y
Source	Medline; PMC
abstract	Few studies have addressed the etiology and clinical outcomes of community-acquired pneumonia (CAP) treated in an ambulatory setting. We investigated the etiology by the culture of Mycoplasma pneumoniae, urine antigen testing of Streptococcus pneumoniae and Legionella pneumoniae, and DNA or RNA determination of eight kinds of respiratory virus DNA or RNA. An etiological diagnosis was made in 51.8% of 197 patients. The most common pathogens were M. pneumoniae (29.4%) followed by influenza virus A, parainfluenza virus, adenovirus, human metapneumovirus (9.6%), and S. pneumoniae (4.1%). Patients with mycoplasma infections were younger, less likely to have comorbidities, and less likely to have adequate sputum for gram stain and culture. Patients with viral infections were older and more likely to have poorly defined nodules on chest X-ray (CXR) or computed tomography (CT) scan. Among patients infected with M. pneumoniae, those with quinolones as initial prescriptions had shorter duration of fever after the initiation of antibiotics than patients with β-lactams, macrolides, or β-lactams + macrolides (p < 0.05). This study suggests that M. pneumoniae and respiratory viruses were the most frequent pathogens found in ambulatory adult CAP patients and quinolones were better than β-lactams, macrolides, or β-lactams + macrolides in the resolution of fever of M. pneumoniae pneumonia.
has issue date	2010-07-11(xsd:dateTime)
bibo:doi	10.1007/s10096-010-1003-2
bibo:pmid	20623362
has license	no-cc
sha1sum (hex)	44b2e6659a6c435fbdd69ac1c6a158db72714c7d
schema:url	https://doi.org/10.1007/s10096-010-1003-2
resource representing a document's title	Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China
has PubMed Central identifier	PMC7088295
has PubMed identifier	20623362
schema:publication	Eur J Clin Microbiol Infect Dis
resource representing a document's body	covid:44b2e6659a6c435fbdd69ac1c6a158db72714c7d#body_text
is schema:about of	named entity 'treated' named entity 'Mycoplasma pneumoniae' named entity 'CAP' named entity 'China' named entity 'CHINA' named entity 'COMMUNITY-ACQUIRED PNEUMONIA' named entity 'BIN' named entity 'DETERMINATION' named entity 'FEI' named entity 'HAVE' named entity 'YOUNGER' named entity 'HUMAN METAPNEUMOVIRUS' named entity 'REN' named entity 'KINDS' named entity 'RNA' named entity 'TREATED' named entity 'MYCOPLASMA PNEUMONIAE' named entity 'PATIENTS' named entity 'EVALUATION' named entity 'OUTCOME' named entity 'AMBULATORY' named entity 'ADULT' named entity 'MYCOPLASMA PNEUMONIAE' named entity 'COMMON' named entity 'LEGIONELLA' named entity 'FOLLOWED BY' named entity 'CAO' named entity 'NOVEL' named entity 'CLINICAL' named entity 'STREPTOCOCCUS PNEUMONIAE' named entity 'ANTIGEN TESTING' named entity 'PATHOGENS' named entity 'URINE' named entity 'INFLUENZA VIRUS A' named entity 'VIRAL AND' named entity 'DNA' named entity 'COMMUNITY-ACQUIRED PNEUMONIA' named entity 'RESPIRATORY VIRUS' named entity 'AMBULATORY' named entity 'SETTING' named entity 'DRS' named entity 'VIRUS DNA' named entity 'INVESTIGATED' named entity 'ADENOVIRUS' named entity 'PATIENTS' named entity 'MYCOPLASMA INFECTIONS' named entity 'CULTURE' named entity 'DIAGNOSIS' named entity 'COMORBIDITIES' named entity 'PARAINFLUENZA VIRUS' named entity 'ETIOLOGY' named entity 'STUDIES' named entity 'PAPER' named entity 'LIKELY' named entity 'CLINICAL OUTCOMES' named entity 'PNEUMONIAE' covid:arg/44b2e6659a6c435fbdd69ac1c6a158db72714c7d named entity 'comorbidities' named entity 'Streptococcus' named entity 'clinical outcomes' named entity 'influenza virus' named entity 'etiological' named entity 'Streptococcus pneumoniae' named entity 'RNA' named entity 'urine' named entity 'pathogens' named entity 'etiology' named entity 'ambulatory' named entity 'M. pneumoniae'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software